The trademark COVISELF was filed by MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED, a corporation established under the laws of the Republic of India (the "Applicant"). The application was published for oppositions on March 30, 2022, and received one opposition filed on June 26, 2022 by Medicago inc. on Likelihood of confusion. the opponent was represented by T MARK CONSEILS and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued June 26, 2022
The application was filed in English, and English was also language of all opposition proceedings (Italian was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Medical diagnostic reagents
Drug testing kits containing primarily medical diagnostic reagents and assays for testing body fluids
Specimen collection kits for use in virus testing consisting primarily of swabs for medical purposes
Pharmaceutical preparations for diagnostic purposes
Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing
Nucleic acid sequences for medical and veterinary purposes
Medical diagnostic test strips
Diagnostic biomarkers for use in assessment of genomic analysis for medical use
Nutritional supplements in tablet form
Medicines in the form of tablets
Therapeutic drugs and agents
Pharmaceutical preparations.
The mark was filed in class 10 with following description of goods:
Medical diagnostic apparatus
Testing apparatus for medical purposes
Apparatus for DNA and RNA testing for medical purposes
Capillary tubes for samples
Apparatus for taking body fluid samples
Medical diagnostic apparatus for testing for viruses
Diagnostic apparatus for the detection of abnormal prion protein
In vitro diagnostic testing apparatus incorporating chemical reagents for medical use
Diagnostic testing apparatus for use in medical immunoassay procedures..
The mark was filed in class 42 with following description of goods:
Laboratory testing
Pharmaceutical testing
Analysis in the field of molecular biology
Design and development of medical diagnostic apparatus
Biomedical research services
Research and development services in the field of genomics
Research laboratories
DNA sequencing for medical research purposes
Software as a service [SaaS]
Scientific laboratory services in the field of genomics
Preparation of biological samples for analysis in research laboratories
Research services in the field of proteins, antibodies, microorganisms and cells
Pharmaceutical research..
The mark was filed in class 44 with following description of goods:
Medical diagnostic services [testing and analysis]
Disease diagnosis services
Medical screening
Medical analysis services for diagnostic purposes provided by medical laboratories
DNA screening for medical purposes
Medical and health services relating to DNA, genetics and genetic testing
Medical laboratory services for the analysis of samples taken from patients..